This is a request to conduct phase 3 of this approved project: CDC proposes to conduct 2 surveys to evaluate the prevalence of healthcare-associated infections (HAIs) and antimicrobial use in acute care hospitals in multiple states. This is a three-phase project. The first phase, a small, single-city pilot survey with less than 9 respondents, is complete. Phases 2 and 3 will be conducted in collaboration with state public health authorities and with CDC's Emerging Infections Program (EIP). Phase 2 will be a limited roll-out survey involving up to 30 healthcare facilities in the 10 states with EIP sites. Phase 3, built upon experience gained in the limited roll-out, will involve up to 500 facilities in the 10 states with EIP sites using the same survey. CDC does not anticipate making changes to the data collection instrument in Phase 3.
PL:
Pub.L. 111 - 5 1
Name of Law: American Recovery and Reinvestment Act of 2009
US Code:
42 USC 241
Name of Law: Public Health Service Act
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
HAI and Antimicrobial Use Point Prevalence Survey - phase 3